Pancreatic Cancer Research

ResearcherActive in the last 2 years

Kazuhiro Seike

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5043546621. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 5

  1. [Multidisciplinary Therapy Mainly Including Surgery for Hemorrhage Due to Duodenal Invasion of Pancreatic Cancer-A Case Report]. Last author PMID 41546309↗
  2. [Postoperative Recurrence of Pancreatic Cancer Successfully Treated with the Gemcitabine plus Oxaliplatin Regimen Resulting in Long-Term Survival-ACase Report]. Co-author PMID 30765668↗
  3. [Long-Term Survival in Response to Multimodality Therapy in a Patient with Invasive Pancreatic Cancer with Cyst Formation]. Co-author PMID 28133201↗
  4. [R0 Resection of Locally Advanced Pancreatic Cancer after Combination Chemotherapy with Gemcitabine and S-1]. Co-author PMID 26805123↗
  5. [A long-term survivor who received S-1-based multidisciplinary therapy for unresectable advanced pancreatic cancer]. Last author PMID 22189235↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hisashi Kametaka · 5 shared papers, 2011–2025 · strength 0.50
  2. Hironobu Makino · 3 shared papers, 2015–2025 · strength 0.38
  3. Yoji Miyahara · 1 shared paper, 2025 · strength 0.25
  4. Akio Hasegawa · 2 shared papers, 2015–2016 · strength 0.13
  5. 牧野裕庸 · 2 shared papers, 2011–2019 · strength 0.13
  6. Ryosuke Okura · 1 shared paper, 2019 · strength 0.09
  7. Masaru Miyazaki · 1 shared paper, 2019 · strength 0.09
  8. Hideyuki Yoshitomi · 1 shared paper, 2019 · strength 0.09
  9. Masaru Isozaki · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.